Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029.
JAMA. 2023.
PMID: 36749332
Free PMC article.
First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors.
Schreiber AR, Kagihara JA, Corr BR, Davis SL, Lieu C, Kim SS, Jimeno A, Camidge DR, Williams J, Heim AM, Martin A, DeMattei JA, Holay N, Triplett TA, Eckhardt SG, Litwiler K, Winkler J, Piscopio AD, Diamond JR.
Schreiber AR, et al.
Cancers (Basel). 2023 Dec 23;16(1):91. doi: 10.3390/cancers16010091.
Cancers (Basel). 2023.
PMID: 38201519
Free PMC article.
Item in Clipboard
Cite
Cite